Koers BioHemp International, Inc. Other OTC
Aandelen
BKIT
US09076B1052
Farmaceutische producten
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Daniel Blum
CEO | Chief Executive Officer | 35 | 15-05-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Daniel Blum
CEO | Chief Executive Officer | 35 | 15-05-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+40,73% | 734 mld. | |
+32,83% | 591 mld. | |
-6,30% | 350 mld. | |
+15,15% | 315 mld. | |
+4,05% | 276 mld. | |
+15,00% | 238 mld. | |
+9,78% | 206 mld. | |
-5,52% | 204 mld. | |
+6,17% | 161 mld. |